Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: A double-blind clinical trial

Background: Prevalence of migraine, as a chronic neurovascular disorder, was approximately 10.3 and 23.1% among men and women, respectively, mostly in people younger than 40 years old. Migraine is prevalent in different geographic areas worldwide. The present study was designed to compare the impact...

Full description

Bibliographic Details
Main Authors: Mahmood Rafieian-kopaei, Ali Hasanpour-dehkordi, Zahra Lorigooini, Fatemeh Deris, Kamal Solati, Faezeh Mahdiyeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:International Journal of Preventive Medicine
Subjects:
Online Access:http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2019;volume=10;issue=1;spage=121;epage=121;aulast=Rafieian-kopaei
_version_ 1818312276403290112
author Mahmood Rafieian-kopaei
Ali Hasanpour-dehkordi
Zahra Lorigooini
Fatemeh Deris
Kamal Solati
Faezeh Mahdiyeh
author_facet Mahmood Rafieian-kopaei
Ali Hasanpour-dehkordi
Zahra Lorigooini
Fatemeh Deris
Kamal Solati
Faezeh Mahdiyeh
author_sort Mahmood Rafieian-kopaei
collection DOAJ
description Background: Prevalence of migraine, as a chronic neurovascular disorder, was approximately 10.3 and 23.1% among men and women, respectively, mostly in people younger than 40 years old. Migraine is prevalent in different geographic areas worldwide. The present study was designed to compare the impact of intranasal lidocaine 4% and peppermint essential oil drop 1.5% on migraine attacks. Methods: In this double-blind, parallel, randomized controlled trial, 120 adult patients with a diagnosis of migraine based on the International Headache Society criteria were treated with intranasal lidocaine drop 4% or peppermint essential oil drop 1.5% or placebo. Patients expressed their symptoms 5 and 15 min after dripping, and if they still had a headache after 15 min, they were given the second dose. Patients with a second dose of medication, 15 min later recorded their headache rate. All patients recorded their symptoms after 30 min. Symptoms of the patients were followed by a researcher through the phone and in-person after 2 months. Then, the questionnaires were filled. Results: In the present study, there was a significant difference among groups in headache intensity after treatment (P < 0.001). In 40% of the patients in the peppermint oil and lidocaine groups, the intensity of headache decreased. In the placebo group, fewer patients responded highly to the treatment, whereas 41.5% of patients in the lidocaine group and 42.1% of patients in the peppermint oil group responded to the treatment considerably. Conclusions: Concerning the findings of the present study, nasal application of peppermint oil caused considerable reduction in the intensity and frequency of headache and relieved majority of patients' pain similar to lidocaine. On the basis of findings of this study, it can be concluded that nasal menthol, such as lidocaine, can be used to relieve migraine headaches.
first_indexed 2024-12-13T08:15:17Z
format Article
id doaj.art-a7bfe320646c41fd9f99a8552b5970d3
institution Directory Open Access Journal
issn 2008-7802
2008-8213
language English
last_indexed 2024-12-13T08:15:17Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Preventive Medicine
spelling doaj.art-a7bfe320646c41fd9f99a8552b5970d32022-12-21T23:54:07ZengWolters Kluwer Medknow PublicationsInternational Journal of Preventive Medicine2008-78022008-82132019-01-0110112112110.4103/ijpvm.IJPVM_530_17Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: A double-blind clinical trialMahmood Rafieian-kopaeiAli Hasanpour-dehkordiZahra LorigooiniFatemeh DerisKamal SolatiFaezeh MahdiyehBackground: Prevalence of migraine, as a chronic neurovascular disorder, was approximately 10.3 and 23.1% among men and women, respectively, mostly in people younger than 40 years old. Migraine is prevalent in different geographic areas worldwide. The present study was designed to compare the impact of intranasal lidocaine 4% and peppermint essential oil drop 1.5% on migraine attacks. Methods: In this double-blind, parallel, randomized controlled trial, 120 adult patients with a diagnosis of migraine based on the International Headache Society criteria were treated with intranasal lidocaine drop 4% or peppermint essential oil drop 1.5% or placebo. Patients expressed their symptoms 5 and 15 min after dripping, and if they still had a headache after 15 min, they were given the second dose. Patients with a second dose of medication, 15 min later recorded their headache rate. All patients recorded their symptoms after 30 min. Symptoms of the patients were followed by a researcher through the phone and in-person after 2 months. Then, the questionnaires were filled. Results: In the present study, there was a significant difference among groups in headache intensity after treatment (P < 0.001). In 40% of the patients in the peppermint oil and lidocaine groups, the intensity of headache decreased. In the placebo group, fewer patients responded highly to the treatment, whereas 41.5% of patients in the lidocaine group and 42.1% of patients in the peppermint oil group responded to the treatment considerably. Conclusions: Concerning the findings of the present study, nasal application of peppermint oil caused considerable reduction in the intensity and frequency of headache and relieved majority of patients' pain similar to lidocaine. On the basis of findings of this study, it can be concluded that nasal menthol, such as lidocaine, can be used to relieve migraine headaches.http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2019;volume=10;issue=1;spage=121;epage=121;aulast=Rafieian-kopaeiheadachelidocainemigraine attackspeppermint oil
spellingShingle Mahmood Rafieian-kopaei
Ali Hasanpour-dehkordi
Zahra Lorigooini
Fatemeh Deris
Kamal Solati
Faezeh Mahdiyeh
Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: A double-blind clinical trial
International Journal of Preventive Medicine
headache
lidocaine
migraine attacks
peppermint oil
title Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: A double-blind clinical trial
title_full Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: A double-blind clinical trial
title_fullStr Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: A double-blind clinical trial
title_full_unstemmed Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: A double-blind clinical trial
title_short Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: A double-blind clinical trial
title_sort comparing the effect of intranasal lidocaine 4 with peppermint essential oil drop 1 5 on migraine attacks a double blind clinical trial
topic headache
lidocaine
migraine attacks
peppermint oil
url http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2019;volume=10;issue=1;spage=121;epage=121;aulast=Rafieian-kopaei
work_keys_str_mv AT mahmoodrafieiankopaei comparingtheeffectofintranasallidocaine4withpeppermintessentialoildrop15onmigraineattacksadoubleblindclinicaltrial
AT alihasanpourdehkordi comparingtheeffectofintranasallidocaine4withpeppermintessentialoildrop15onmigraineattacksadoubleblindclinicaltrial
AT zahralorigooini comparingtheeffectofintranasallidocaine4withpeppermintessentialoildrop15onmigraineattacksadoubleblindclinicaltrial
AT fatemehderis comparingtheeffectofintranasallidocaine4withpeppermintessentialoildrop15onmigraineattacksadoubleblindclinicaltrial
AT kamalsolati comparingtheeffectofintranasallidocaine4withpeppermintessentialoildrop15onmigraineattacksadoubleblindclinicaltrial
AT faezehmahdiyeh comparingtheeffectofintranasallidocaine4withpeppermintessentialoildrop15onmigraineattacksadoubleblindclinicaltrial